These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9507504)

  • 1. Tubulo-interstitial damage in glomerular diseases: its role in the progression of the renal damage.
    D'Amico G
    Nephrol Dial Transplant; 1998; 13 Suppl 1():80-5. PubMed ID: 9507504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tubulo-interstitial lesions in glomerular diseases].
    Uchida S
    Nihon Naika Gakkai Zasshi; 1999 Aug; 88(8):1423-7. PubMed ID: 10475001
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current view on mediators role in pathogenesis of renal interstitial fibrosis (review)].
    Ratner MIa
    Ter Arkh; 1997; 69(12):87-8. PubMed ID: 9503546
    [No Abstract]   [Full Text] [Related]  

  • 4. Progression of renal disease and renal hypertrophy.
    Hostetter TH
    Annu Rev Physiol; 1995; 57():263-78. PubMed ID: 7778868
    [No Abstract]   [Full Text] [Related]  

  • 5. The contribution of cell culture to the study of renal diseases.
    Striker LJ; Tannen RL; Lange MA; Striker GE
    Int Rev Exp Pathol; 1988; 30():55-105. PubMed ID: 3061964
    [No Abstract]   [Full Text] [Related]  

  • 6. Glomerular and tubular induction of the transcription factor c-Jun in human renal disease.
    De Borst MH; Prakash J; Melenhorst WB; van den Heuvel MC; Kok RJ; Navis G; van Goor H
    J Pathol; 2007 Oct; 213(2):219-28. PubMed ID: 17891746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulointerstitial changes as a major determinant in the progression of renal damage.
    Nath KA
    Am J Kidney Dis; 1992 Jul; 20(1):1-17. PubMed ID: 1621674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubulointerstitial damage leads to atubular glomeruli: significance and possible role in progression.
    Marcussen N
    Nephrol Dial Transplant; 2000; 15 Suppl 6():74-5. PubMed ID: 11143999
    [No Abstract]   [Full Text] [Related]  

  • 9. Diseased renal glomeruli are getting soft. Focus on "Biophysical properties of normal and diseased renal glomeruli".
    Pozzi A
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C394-6. PubMed ID: 21178112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of tubulo-interstitial changes in glomerular excretory and urine concentrating function of the kidney].
    Bohle A; Mackensen-Haen S; von Gise H
    Zentralbl Allg Pathol; 1986; 132(5-6):351-63. PubMed ID: 3551391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubulo-interstitial alterations in type I membranoproliferative glomerulonephritis. An investigation of 259 cases.
    Schmitt H; Cavalcanti de Oliveira V; Bohle A
    Pathol Res Pract; 1987 Feb; 182(1):6-10. PubMed ID: 3588405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys.
    Bonofiglio R; Antonucci MT; Papalia T; Romeo F; Capocasale G; Caroleo MC; Di Fausto V; Aloe L
    J Nephrol; 2007; 20(2):186-95. PubMed ID: 17514623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis.
    Castoldi G; di Gioia C; Giollo F; Carletti R; Bombardi C; Antoniotti M; Roma F; Zerbini G; Stella A
    Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):335-42. PubMed ID: 26700017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies.
    Schmid H; Cohen CD; Henger A; Irrgang S; Schlöndorff D; Kretzler M
    Kidney Int; 2003 Jul; 64(1):356-60. PubMed ID: 12787429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.
    Pontrelli P; Rossini M; Infante B; Stallone G; Schena A; Loverre A; Ursi M; Verrienti R; Maiorano A; Zaza G; Ranieri E; Gesualdo L; Ditonno P; Bettocchi C; Schena FP; Grandaliano G
    Transplantation; 2008 Jan; 85(1):125-34. PubMed ID: 18192922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid accumulation of plasma acid-stable trypsin inhibitor in experimental acute renal injury.
    Maruyama M; Yoshida E; Sugiki M; Mihara H; Sumi H; Sakai R
    Enzyme; 1991; 45(1-2):54-62. PubMed ID: 1806366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glomerulo-tubular junction: a target in renal diseases.
    Lindop GB; Gibson IW; Downie TT; Vass D; Cohen EP
    J Pathol; 2002 May; 197(1):1-3. PubMed ID: 12081194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubular vimentin metaplasia in canine nephropathies.
    Vilafranca M; Domingo M; Ferrer L
    Res Vet Sci; 1994 Sep; 57(2):248-50. PubMed ID: 7817015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat.
    Chen CO; Park MH; Forbes MS; Thornhill BA; Kiley SC; Yoo KH; Chevalier RL
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F946-55. PubMed ID: 17107943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.